BWXT

Download the Complete Report Here Key Takeaways: 1Q26 showed progress across IMSR’s key commercialization vectors, with regulatory, DOE program, supply-chain, commercial pipeline, and liquidity milestones collectively advancing the de-risking narrative. IMSR continues to execute against a milestone-driven roadmap that is more appropriately measured by regulatory progress, project pipeline development, fuel readiness, supply-chain qualification, and cash runway than by near-term revenue. The quarter advanced all three of management’s stated pillars: IMSR engineering and regulatory programs, including DOE-backed TETRA and TEFLA projects; supply-chain development, including materials testing and supplier execution; and commercial pipeline expansion, led by the Riot Platforms collaboration. The company reported a 1Q26 net loss of $10.5 million, ended the quarter with $289.9 million of cash and investments, and reported quarterly cash burn of $7.9 million, while expanding its commercial pipeline to ~10 IMSR Plant projects representing 7.8GW of indicative power capacity. NRC approval of the PIE Topical Report adds another foundational element to IMSR’s licensing basis. In May, the NRC issued its Safety Evaluation Report approving IMSR’s Postulated Initiating Events methodology, following acceptance of the company’s final submission in April 2026. The approval validates IMSR’s framework for identifying and evaluating events that could challenge safe plant operation, making it a core safety-analysis milestone rather than a process update. Importantly, approved Topical Reports can be referenced in future operating license applications without repetitive re-evaluation, reducing review scope and supporting standardized outcomes across multiple IMSR deployments. The PIE approval builds on the NRC’s September 2025 approval of IMSR’s Principal Design Criteria, which addressed foundational safety and design requirements, including inherent safety, reactor power control, and load-following capability. The regulatory pathway is increasingly defined around operating-license readiness and repeat deployment. Construction permits enable large-scale plant construction and address major environmental requirements, while operating-license preparedness determines whether the nuclear systems satisfy safety standards for commercial operation. IMSR’s Topical Reports are most relevant t...

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. BWX Technologies (BWXT) is back in focus after reporting first quarter 2026 results that topped Wall Street expectations, raising full year guidance and landing more than US$1.4b in new U.S. Navy nuclear contracts. See our latest analysis for BWX Technologies. Even after a recent pullback, with a 30 day share price return down 11.47%, BWX Technologies still shows strong momentum. The year to date share price return is 16.00% and the 1 year total shareholder return is 95.09%, reflecting how investors are reacting to contract wins, raised guidance and dividend continuity. If BWXT’s nuclear contracts have caught your attention, it could be worth seeing what else is shaping the sector and checking out 87 nuclear energy infrastructure stocks After a strong 1 year total return and fresh contract wins, BWX Technologies is no longer flying under the radar. The key question now is whether the recent pullback leaves upside on the table or if the market is already pricing in future growth. According to a widely followed narrative by user Zaleznog, BWX Technologies' fair value of $130 sits well below the recent close at $210.94, setting up a clear tension between market price and narrative valuation. Read the complete narrative. Curious how a mature industrial stock arrives at a tech style valuation multiple? This narrative leans on specific growth, margin and discount rate assumptions that sharply constrain its fair value range, and the gap to today’s share price is not small. Result: Fair Value of $130 (OVERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, if BWXT integrates acquisitions more smoothly than feared or if contracts convert to cash flow with fewer accounting shocks, this overvaluation thesis could face pressure. Find out about the key risks to this BWX Technologies narrative. If this mix of risks and rewards feels finely balanced, consider taking action while the debate is fresh and weigh both sides against the 2 key rewards and 1 important warning sign. If BWX Technologies has sharpened your interest, do not stop here. Use the screener to uncover other stocks that could fit neatly into your watchlist. Spot potential bargains quickly by checking companies that screen as 47 high quality undervalu...

BWX’s first quarter results for 2026 exceeded Wall Street’s expectations for both revenue and non-GAAP earnings, but the market reaction was notably negative. Management attributed the performance to higher throughput, strong operational execution, and robust demand in both government and commercial segments. CEO Rex Geveden pointed to “improved throughput, favorable pacing of work, and exceptional operational execution” as major contributors. The company also highlighted a significant year-over-year increase in backlog, which management believes offers clear visibility for future growth. Is now the time to buy BWXT? Find out in our full research report (it’s free). Revenue: $860.2 million vs analyst estimates of $837.3 million (26.1% year-on-year growth, 2.7% beat) Adjusted EPS: $1.12 vs analyst estimates of $0.93 (21% beat) Adjusted EBITDA: $148 million vs analyst estimates of $134.8 million (17.2% margin, 9.8% beat) Management raised its full-year Adjusted EPS guidance to $4.68 at the midpoint, a 1.1% increase EBITDA guidance for the full year is $657.5 million at the midpoint, above analyst estimates of $651.3 million Operating Margin: 12.4%, down from 14.2% in the same quarter last year Backlog: $8.65 billion at quarter end, up 77.3% year on year Market Capitalization: $18.81 billion While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention. Matthew Akers (BNP Paribas): Asked about the price and strategic rationale for the PCG acquisition. CFO Michael Fitzgerald clarified the price was around $200 million and emphasized both capacity needs and workforce quality as drivers for the acquisition. Jeffrey Campbell (Seaport Research Partners): Inquired about limitations of the new commercial facility and its ability to serve different nuclear customers. Fitzgerald explained the planned facility would have no such limitations and would be structured as a center of excellence for various component types. Marc Bianchi (TD Cowen): Asked about BWX’s competitive positioning in TRISO fuel and expansion plans. CEO Rex Geveden explained BWX is currently the only producer at scale, with plans for further capacity to bring down costs and...

BWX Technologies, Inc. recently reported first-quarter 2026 results, with sales rising to US$860.22 million and net income to US$91.07 million, while also declaring a US$0.27 per-share quarterly dividend payable on June 5, 2026 to shareholders of record on May 19, 2026. Alongside beating earnings expectations, BWX Technologies raised its 2026 revenue guidance above US$3.75 billion and moved to expand nuclear manufacturing capacity through the planned acquisition of Precision Components Group, reinforcing its push into commercial nuclear markets. Now we’ll examine how BWX Technologies’ raised 2026 guidance and nuclear capacity expansion plans influence the existing investment narrative and risks. AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. To own BWX Technologies, you need to believe in a long runway for defense and nuclear power work, supported by a deep, multi-year backlog. The key short term catalyst remains execution on this record pipeline and scaling new capacity. The biggest risk is still BWXT’s dependence on large U.S. government contracts, which could introduce earnings volatility if priorities change. The latest quarter’s results and guidance tweak do not materially alter that core risk reward balance. The announcement that stands out most here is BWXT’s plan to acquire Precision Components Group to expand U.S. nuclear manufacturing capacity. This move ties directly into the catalyst of rising nuclear demand, particularly in commercial markets, and could help BWXT turn its growing order book into billable work more efficiently. At the same time, it may increase capital intensity, which matters if growth slows or margins in commercial operations remain under pressure. Yet behind the strong backlog and capacity build out, investors should still be aware of how concentrated BWXT remains in U.S. government spending... Read the full narrative on BWX Technologies (it's free!) BWX Technologies’ narrative projects $4.5 billion revenue and $530.5 million earnings by 2029. This implies 12.4% yearly revenue growth and about a $201.6 million earnings increase from $328.9 million today. Uncover how BWX Technologies' forecasts yield a $232.27 fair value, a 8% upside to its current price. Some of the...

BWX Technologies, Inc. (NYSE:BWXT) is among the 10 Best Large Cap Defense Stocks to Buy According to Hedge Funds. On May 4, the company announced robust financial results for Q1 2026, beating Wall Street’s estimates for both revenue and earnings. Revenue for the quarter was reported at $860.2 million, up 26% from the prior year. Earnings per share came in at $1.12, surpassing estimates by 20 cents, and improving 22% year-over-year. The management credited the results to improved operational performance, which included order backlog execution. The company raised its guidance for full-year revenue, non-GAAP EPS, adjusted EBITDA, and free cash flow. The new forecast does not account for contributions from the planned acquisition of Precision Components Group, LLC (PCG). On April 20, BWX Technologies, Inc. (NYSE:BWXT) said that it had reached an agreement to acquire PCG. The move is set to strengthen the company’s heavy manufacturing capabilities and expand its nuclear production capacity for commercial use in the United States. According to the press release, PCG will be included in BWXT’s Commercial Operations segment. The transaction is anticipated to close during the back half of 2026. In other news, the company is seeking a uranium enrichment license to build a new facility next to Erwin’s Nuclear Fuel Services (NFS) facility. The Nuclear Regulatory Commission was informed about the plan last month. BWX Technologies, Inc. (NYSE:BWXT) is focused on providing nuclear solutions for global security, environmental protection, clean energy, and space exploration. The stock has returned 13% year-to-date, as of the close on May 5. While we acknowledge the potential of BWXT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 15 Best Big Name Stocks to Buy and 10 Best Military Drone Stocks to Buy Right Now. Disclosure: None. Follow Insider Monkey on Google News.

First quarter outperformance was driven by improved throughput, favorable work pacing, and exceptional operational execution across all business lines. Management is prioritizing the establishment of a U.S. commercial nuclear manufacturing footprint to complement existing Canadian operations and meet accelerating global demand. The acquisition of Precision Components Group (PCG) provides immediate access to a qualified nuclear workforce and available capacity for commercial reactor internals and heat exchangers. Government Operations growth is increasingly supported by special materials programs, including defense fuels enrichment and the new High-Assay Low-Enriched Uranium (HALEU) contract. Commercial nuclear demand is shifting toward localized supply chains, which management believes will serve as a key competitive differentiator for future SMR and large reactor projects. Operational excellence initiatives (DPX) are being utilized to maximize existing capacity through increased throughput, reducing the immediate need for capital-intensive square footage expansion. Full-year 2026 guidance assumes a back-half weighted earnings profile, with approximately 55% of full-year EBITDA expected in the second half. Management intends to expand U.S. commercial capacity via a potential greenfield plant at the Mount Vernon site, capable of producing heavy equipment like steam generators. The defense fuels and HALEU programs are expected to ramp through 2026, transitioning from supply chain organization to facility construction and eventual production. Strategic investments in advanced nuclear and medical isotopes are expected to drive high-teens growth in the medical segment and low-teens growth in commercial power. Future capital expenditures may exceed the 6% of sales target to approximately 7% if the company moves forward with large-scale U.S. manufacturing expansions. The $200 million acquisition of PCG is expected to close in the second half of 2026; the business generated approximately $125 million in revenue in 2025 and is expected to see mid-single digit revenue growth in 2026. Management identified project delivery risk for the broader nuclear industry as a primary macro headwind, though they cited Canadian refurbishment successes as a positive counter-indicator. The company is engaging with the NRC regarding plans for a High-Enriched Uranium (HEU) enrichment f...

BWX Technologies (BWXT) reported Q1 adjusted earnings late Monday of $1.12 per diluted share, up fro

Dow Jones Futures: Iran attacks sparked stock market losses Monday. Palantir stock dropped on earnings late.

Q1 beat expectations: Revenue rose 26% year‑over‑year (11% organic), adjusted EBITDA was up 14% and adjusted EPS increased 22% to $1.12, while total backlog jumped to $8.7 billion, up 77% year‑over‑year. Commercial manufacturing push and PCG deal: BWXT agreed to acquire Precision Components Group for roughly $200 million to add two U.S. facilities (400+ employees) and shift capacity toward commercial nuclear work, while also exploring a greenfield plant at Mount Vernon for larger components. Updated 2026 outlook: BWXT raised adjusted EBITDA guidance to $650–$665 million, reaffirmed revenue of at least $3.75 billion and FCF of $315–$330 million, with capex around 6% of sales but potentially ~7% if a new greenfield plant proceeds. Interested in BWX Technologies, Inc.? Here are five stocks we like better. 3 Overlooked Nuclear Fuel Supply Chain Winners BWX Technologies (NYSE:BWXT) reported what President and CEO Rex Geveden called “a great start to 2026,” posting first-quarter results that came in ahead of management expectations and were supported by higher throughput, favorable pacing of work, and operational execution across business lines. Geveden said first-quarter revenue increased 26% year-over-year, including 11% organic growth. Adjusted EBITDA rose 14% and earnings per share increased 22%. → Roblox Stock Slides to New Low as Safety Changes Weigh on Outlook Nuclear's Pullback: A Generational Buying Opportunity? Senior Vice President and CFO Mike Fitzgerald said first-quarter revenue totaled $860 million, while adjusted EBITDA was $148 million. Adjusted EPS was $1.12, up 22%, which Fitzgerald said reflected “strong operating performance” and about $0.08 of higher non-operating contributions. The adjusted effective tax rate was 15.8%, benefiting from the timing of stock compensation, and free cash flow was $50 million, which Fitzgerald called “a strong result for what is typically our seasonally weakest quarter.” BWXT ended the quarter with total backlog of $8.7 billion, which Geveden said was up 77% year-over-year and 19% sequentially, driven by “robust bookings in government and consistent backlog in commercial.” → The Real SpaceX Play: 5 Chip Stocks Powering the IPO Before It Launches Investors Flock to Uranium as Nuclear Renaissance Builds BWXT emphasized rising demand for commercial nuclear components and services across the U.S., Canada, and Europe,...

BWX Technologies (BWXT) came out with quarterly earnings of $1.12 per share, beating the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $0.91 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +21.59%. A quarter ago, it was expected that this supplier of nuclear fuel and components to the U.S. government would post earnings of $0.91 per share when it actually produced earnings of $1.08, delivering a surprise of +18.68%. Over the last four quarters, the company has surpassed consensus EPS estimates four times. BWX, which belongs to the Zacks Aerospace - Defense Equipment industry, posted revenues of $860.22 million for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 5.09%. This compares to year-ago revenues of $682.26 million. The company has topped consensus revenue estimates four times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. BWX shares have added about 25.2% since the beginning of the year versus the S&P 500's gain of 5.6%. While BWX has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for BWX was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of toda...

Monday, BWX Technologies reported first-quarter earnings per share of $1.12 from sales of $860.2. million.

Nuclear stocks Cameco and BWX Technologies both traded near buy points on Tuesday morning after reporting better-than-expected first-quarter earnings. Cameco is the "sole vertically integrated nuclear company," from uranium mining and refining to providing the reactor core via its 49% stake in Westinghouse Electric, William Blair analyst Jed Dorsheimer wrote in an April 20 coverage initiation. BWX is the U.S. Navy's main nuclear reactor supplier though its recent growth is being fueled by its commercial business.